Logo image of PRLD

PRELUDE THERAPEUTICS INC (PRLD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:PRLD - US74065P1012 - Common Stock

1.35 USD
-0.2 (-12.9%)
Last: 12/2/2025, 4:04:03 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
PRLD revenue by date.PRLD revenue by date.
7M
-100.00%
102M70.319M
-31.06%
103.77M
47.57%
164.83M
58.84%
246.76M
49.71%
EBITDA
YoY % growth
PRLD ebitda by date.PRLD ebitda by date.
-122.22M
-8.33%
-131.108M
-7.27%
-137.942M
-5.21%
-170.968M
-23.94%
-185.985M
-8.78%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PRLD ebit by date.PRLD ebit by date.
-123.54M
-8.62%
-132.277M
-7.07%
-139.714M
-5.62%
-132.855M
4.91%
-135.099M
-1.69%
-145.146M
-7.44%
113.42M
178.14%
43.758M
-61.42%
72.624M
65.97%
-30.6M
-142.13%
-31.62M
-3.33%
Operating Margin
PRLD operating margin by date.PRLD operating margin by date.
N/AN/A-1,995.91%N/AN/AN/A111.20%62.23%69.99%-18.56%-12.81%
EPS
YoY % growth
PRLD eps by date.PRLD eps by date.
-2.44
-0.83%
-2.03
16.80%
-1.69
16.75%
-1.41
16.66%
-0.97
30.89%
-0.83
14.24%
-1.22
-46.64%
-0.90
26.67%
-0.53
40.91%
-0.21
59.62%
0.15
171.43%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28
EPS
Q2Q % growth
-0.03
92.22%
-0.19
55.07%
-0.19
52.48%
0.13
150.41%
-0.34
-1,058.62%
-0.28
-49.73%
-0.25
-30.37%
-0.27
-306.23%
-0.30
11.90%
-0.30
-7.22%
-0.30
-20.08%
Revenue
Q2Q % growth
35.7M
792.50%

-100.00%

-100.00%
N/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
2.125M
106.28%
-19.095M
50.87%
-19.457M
46.39%
31.437M
253.97%
-36.553M
-1,820.13%
N/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.26
39.53%
-0.370.1130.21%
Q2 2025
Q2Q % growth
-0.41
10.87%
-0.450.048.54%
Q1 2025
Q2Q % growth
-0.42 -0.480.0612.08%
Q4 2024
Q2Q % growth
-0.38
17.39%
-0.470.0919.59%
Q3 2024
Q2Q % growth
-0.43
4.44%
-0.480.0510.65%
Q2 2024
Q2Q % growth
-0.46
14.81%
-0.44-0.02-4.88%
Q1 2024
Q2Q % growth
-0.42
27.59%
-0.490.0715.10%
Q4 2023
Q2Q % growth
-0.46
23.33%
-0.500.047.96%
Q3 2023
Q2Q % growth
-0.45
28.57%
-0.590.1424.24%
Q2 2023
Q2Q % growth
-0.54
6.90%
-0.650.1116.41%
Q1 2023
Q2Q % growth
-0.58
7.94%
-0.700.1216.99%
Q4 2022
Q2Q % growth
-0.60
15.49%
-0.640.046.33%
Q3 2022
Q2Q % growth
-0.63
4.55%
-0.650.022.89%
Q2 2022
Q2Q % growth
-0.58 -0.620.046.78%
Q1 2022
Q2Q % growth
-0.63
-34.04%
-0.660.034.98%
Q4 2021
Q2Q % growth
-0.71
-57.78%
-0.70-0.01-1.99%
Q3 2021
Q2Q % growth
-0.66
87.43%
-0.64-0.02-3.53%
Q2 2021
Q2Q % growth
-0.58 -0.50-0.08-15.11%
Q1 2021
Q2Q % growth
-0.47 -0.43-0.04-8.68%
Q4 2020
Q2Q % growth
-0.45 -0.480.035.63%
Q3 2020
Q2Q % growth
-5.25 -0.44-4.81-1,096.99%
PRLD Yearly EPS VS EstimatesPRLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
6.5M
116.67%
6.5M%
PRLD Yearly Revenue VS EstimatesPRLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2028 2029 2030 2031 2032 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS88.65% 89.38% 0% 2.99%
RevenueN/A N/A N/A N/A